On October 12, Vylor spinco rose 3.04% in regular trading, trading at $75.34 per share, with turnover of $63.91 million. UBS initiated coverage of Vylor spinco on the same day with a Buy rating and an $89 price target, the highest among recent initiations by Wall Street banks, serving as the direct catalyst for the short-term rally.
October 12 marks the latest in a series of analyst initiations following the company's spinoff from Corteva and its addition to the S&P 500 index on October 1. RBC Capital Markets previously initiated coverage with an Outperform rating and an $85 price target, highlighting what they described as a differentiated licensing engine, and Morgan Stanley initiated coverage with an Overweight rating and an $85 target. FactSet data showed an average rating of Buy and a mean price target around $81.91 for Vylor spinco. UBS's $89 target represented a notable premium to the consensus, reinforcing positive sentiment toward the pure-play seed and genetics company.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments